Royalty Pharma Plc (RPRX)
69.31
+0.34
(+0.49%)
USD |
NASDAQ |
Nov 13, 16:00
69.30
0.00 (0.00%)
After-Hours: 19:59
Royalty Pharma Price : 69.31 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 68.76 | 69.42 | 68.14 | 69.31 | 2.951M |
| Nov 12, 2026 | 70.34 | 70.37 | 68.75 | 68.97 | 3.785M |
| Nov 11, 2026 | 69.04 | 70.27 | 68.88 | 70.01 | 3.533M |
| Nov 10, 2026 | 68.47 | 69.63 | 67.73 | 69.45 | 3.421M |
| Nov 09, 2026 | 67.50 | 69.04 | 66.93 | 68.77 | 3.738M |
| Nov 06, 2026 | 66.52 | 68.15 | 66.52 | 67.30 | 4.837M |
| Nov 05, 2026 | 68.00 | 69.77 | 67.51 | 67.57 | 4.897M |
| Nov 04, 2026 | 65.65 | 67.66 | 64.84 | 67.56 | 3.796M |
| Nov 03, 2026 | 66.57 | 67.44 | 66.12 | 66.40 | 3.175M |
| Nov 02, 2026 | 66.97 | 67.10 | 66.42 | 66.52 | 2.873M |
| Oct 30, 2026 | 67.00 | 67.70 | 66.40 | 67.18 | 4.662M |
| Oct 29, 2026 | 65.34 | 66.29 | 64.93 | 65.93 | 2.450M |
| Oct 28, 2026 | 64.82 | 65.34 | 63.48 | 64.82 | 2.415M |
| Oct 27, 2026 | 64.71 | 65.50 | 64.45 | 65.28 | 2.702M |
| Oct 26, 2026 | 64.14 | 65.35 | 64.06 | 64.76 | 4.108M |
| Oct 23, 2026 | 63.50 | 63.97 | 63.01 | 63.86 | 4.016M |
| Oct 22, 2026 | 62.34 | 63.84 | 62.34 | 63.75 | 2.808M |
| Oct 21, 2026 | 62.10 | 62.90 | 62.00 | 62.15 | 2.742M |
| Oct 20, 2026 | 60.92 | 62.42 | 60.78 | 62.25 | 2.493M |
| Oct 19, 2026 | 60.54 | 61.12 | 60.04 | 60.27 | 2.813M |
| Oct 16, 2026 | 59.89 | 61.31 | 59.72 | 60.96 | 5.787M |
| Oct 15, 2026 | 59.75 | 60.41 | 59.50 | 59.62 | 3.407M |
| Oct 14, 2026 | 56.93 | 59.08 | 56.78 | 58.99 | 2.828M |
| Oct 13, 2026 | 57.70 | 57.97 | 56.42 | 56.57 | 3.582M |
| Oct 12, 2026 | 57.04 | 57.92 | 56.85 | 57.78 | 2.465M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 147.76 |
| ANI Pharmaceuticals, Inc. | 71.44 |
| Corcept Therapeutics, Inc. | 72.94 |
| Veru, Inc. | 2.09 |
| Johnson & Johnson | 285.75 |
Price Related Metrics
| PE Ratio | 45.10 |
| PS Ratio | 13.90 |
| Price to Book Value | 4.520 |
| Price to Free Cash Flow | 28.44 |
| Earnings Yield | 2.22% |
| Market Cap | 30.90B |
| Operating PE Ratio | 21.21 |
| Normalized PE Ratio | 38.69 |